| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Biotechnology Kiosk |
2021―Aug―25 |
Advanced Nanomaterial Based Solutions to Mitigate the Challenges of COVID-19 Pandemic |
Ashish Yadav, Ashish Mathur, Zheng Hongyu, Rajeev Gupta, John Kirabira, Kenneth Ssekataawa |
| 2 |
[GO] |
Biotechnology Kiosk |
2021―Jul―07 |
On-Chip PCR Based Plasmonic Microfluidic Platform: Ultrafast Point-of-Care Diagnostics of SARS-CoV-2 |
Megha Agrawal |
| 3 |
[GO] |
Biotechnology Kiosk |
2021―Apr―23 |
COVID-19 reveals redox vulnerabilities in two minority groups |
Adonis Sfera, Afzaal Jafri, Jason Thomas, Carlos Manuel Zapata-Martín del Campo, Daniel Gehlbach, Carolina Osorio |
| 4 |
[GO] |
Biotechnology Kiosk |
2020―Dec―21 |
Combating the pandemic with a potential cure: A thermostable mRNA vaccine emerges as a promising candidate against COVID-19 |
Shripriya Singh |
| 5 |
[GO] |
Biotechnology Kiosk |
2020―Dec―21 |
Materials for diagnosis, prevention and control of covid-19 pandemic |
Rajeev Gupta |
| 6 |
[GO] |
Biotechnology Kiosk |
2020―Nov―04 |
Options for COVID-19 therapeutics: Aerosolized inhalation antibody-conjugated Nano particles. |
Humphrey Simukokoa |
| 7 |
[GO] |
Biotechnology Kiosk |
2020―Jul―21 |
Neutralizing antibodies: Viable treatment modality for COVID-19 |
Sangeeta Chakraborty |
| 8 |
[GO] |
Biotechnology Kiosk |
2020―Jul―21 |
Global pandemic takes a toll on our brain health: how unexpected uncertainty makes you vulnerable to paranoia |
Shripriya Singh |
| 9 |
[GO] |
Biotechnology Kiosk |
2020―Jul―09 |
Innovations in Therapeutics to Control COVID-19 |
Shyamasri Biswas |
| 10 |
[GO] |
Biotechnology Kiosk |
2020―Jul―09 |
Impact of COVID-19 on cardiovascular patients |
Sangeeta Chakraborty |
| 11 |
[GO] |
Biotechnology Kiosk |
2020―Jul―09 |
The Need for Next Generation Diagnostic and Surveillance Technologies to Battle SARS-CoV-2 Pandemic |
Megha Agrawal |
| 12 |
[GO] |
Biotechnology Kiosk |
2020―Mar―23 |
Can Antiviral Drugs Stop Coronavirus (COVID-19)? |
Megha Agrawal |
| 13 |
[GO] |
Biotechnology Kiosk |
2020―Mar―23 |
Structural Pathways to Developing Vaccines against Novel Coronavirus (SARS-CoV-2) |
Shyamasri Biswas |
